What Analysts Are Saying About Amgen Stock - Nasdaq

3 days ago · Analysts' ratings for Amgen (NASDAQ:AMGN) over the last quarter vary from bullish to bearish, ... What Analysts Are Saying About Amgen Stock November 14, 2024 — 09:01 am EST.

CouponFollow Extension

$338.45
OFF

In-Depth Examination Of 11 Analyst Recommendations For …

1 week from now

Oct 14, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Amgen, presenting an average target of $338.45, a high estimate of $405.00, and a low estimate of …

nasdaq.com

$286
OFF

20 Analysts Have This To Say About Amgen | Markets Insider

1 week from now

Nov 9, 2023 · These 20 analysts have an average price target of $286.1 versus the current price of Amgen at $265.67, implying upside. Below is a summary of how these 20 analysts rated …

businessinsider.com

$260.57
OFF

7 Analysts Have This To Say About Amgen | Markets Insider

1 week from now

Jun 26, 2023 · These 7 analysts have an average price target of $260.57 versus the current price of Amgen at $224.73, implying upside. Below is a summary of how these 7 analysts rated …

businessinsider.com

64%
OFF

Amgen Call Volume Above Normal And Directionally Bullish - Nasdaq

1 week from now

3 days ago · Bullish option flow detected in Amgen (AMGN) with 8,403 calls trading, 2x expected, and implied vol increasing over 3 points to 49.64%. Jan-25 295 calls and Jan-27 300 calls are …

nasdaq.com

16%
OFF

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

1 week from now

2 days ago · While Amgen's (AMGN-4.16%) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

fool.com

7%
OFF

Amgen Defends Its Investigational Monthly Weight Loss Injection …

1 week from now

4 days ago · Also Read: Jim Cramer Says Eli Lilly’s ‘Pathetic’ Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop. Analysts referred to new …

yahoo.com

$25
OFF

What 4 Analyst Ratings Have To Say About Adient | Nasdaq

1 week from now

3 days ago · In the assessment of 12-month price targets, analysts unveil insights for Adient, presenting an average target of $25.0, a high estimate of $30.00, and a low estimate of $19.00.

nasdaq.com

FAQs about What Analysts Are Saying About Amgen Stock - Nasdaq Coupon?

Should you buy Amgen stock?

The 18 analysts with 12-month price forecasts for Amgen stock have an average target of 331.78, with a low estimate of 215 and a high estimate of 405. The average target predicts an increase of 3.93% from the current stock price of 319.22. The average analyst rating for Amgen stock from 20 stock analysts is "Buy". ...

How do analysts evaluate Amgen (Amgen) stock?

Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Amgen compared to the broader market. Price Targets: Analysts set price targets as an estimate of a stock's future value. ...

What are Amgen analyst ratings?

Stay up to date on Amgen analyst ratings. Analyst Ratings: What Are They? Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). ...

Should you buy Amgen (AMGN)?

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amgen in the last year. There is currently 1 sell rating, 11 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMGN shares. ...

What is the average price target for Amgen (Amgen)?

These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. These 7 analysts have an average price target of $260.57 versus the current price of Amgen at $224.73, implying upside. ...

How many analysts have commented on Amgen (AMGN) stock?

Over the past 3 months, 7 analysts have published their opinion on Amgen (NASDAQ:AMGN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. ...